Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous CD34+ stem cells (Odessa National Medical University)
- Development stage
- Unknown
- Lead developer
- Odessa University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intramyocardial
01
Overview
This autologous cell therapy involves the intramyocardial implantation of peripheral blood mononuclear cells enriched for CD34+ stem cells. Developed by Odessa National Medical University, the treatment is specifically investigated for patients with ischemic cardiomyopathy. The protocol includes a preparatory course of cardiac shock-wave therapy (SWT) intended to prime the myocardium before the cells are delivered via the NOGA.XP electromechanical mapping and navigation system. The therapy aims to stimulate angiogenesis, reduce fibrotic tissue, and improve overall cardiac function in patients with chronic myocardial ischemia.
- Other names
- Autologous peripheral mononuclear cells with CD34+ stem cellsCD34+ stem cells
Beyond the preview
Go deeper on Autologous CD34+ stem cells (Odessa National Medical University).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Autologous CD34+ stem cells (Odessa National Medical University).